What is child pugh score

Reading File

Finding Sources

Searching the Web

Child-Pugh score liver cirrhosis scoring system criteria interpretation

Reading File

Child-Pugh Score (Child-Turcotte-Pugh Score)

The Child-Pugh score is a clinical scoring system that assesses the severity of chronic liver disease, mainly cirrhosis, and predicts prognosis and operative mortality. It was first proposed by Child and Turcotte in 1964, then modified by Pugh in 1973, originally to estimate operative mortality in patients with bleeding esophageal varices.

Scoring Parameters

Each of the 5 parameters is scored 1-3 points:

Parameter	1 point	2 points	3 points
Ascites	Absent	Slight	Moderate
Bilirubin (mg/dL)	≤ 2	2-3	> 3
Albumin (g/dL)	> 3.5	2.8-3.5	< 2.8
INR	< 1.7	1.8-2.3	> 2.3
Encephalopathy	None	Grade 1-2	Grade 3-4

(Either prothrombin time or INR should be used, not both)

Classification and Prognosis

Total Points	Child Class	Liver Status	Operative Mortality
5-6	A	Well-compensated cirrhosis	2-10%
7-9	B	Significant functional compromise	12-31%
10-15	C	Decompensated cirrhosis	12-82%

1-year survival: Class A ~100%, Class B ~81%, Class C ~45% 2-year survival: Class A ~85%, Class B ~57%, Class C ~35%

Clinical Uses

Prognosis - predicts mortality in cirrhosis
Surgery risk stratification - Class C patients have 70-80% mortality after abdominal surgery; Class A patients are generally safe for elective surgery
Liver transplant listing - guides transplant decisions
Drug dosing - pharmaceutical companies use Child-Pugh class to recommend dose adjustments (e.g., caspofungin dose reduction in Class B)
Variceal bleeding risk - 40% of Class A patients have varices vs. 85% in Class C

Limitations

Subjective parameters (ascites, encephalopathy grading)
Poor differentiation at extremes (two patients with different lab values can get the same score)
Largely superseded by the MELD score (and MELD-Na) for predicting mortality in end-stage liver disease, since MELD uses objective values (INR, creatinine, bilirubin) and better predicts mortality in transplant candidates

The MELD score formula: 3.8 x log(bilirubin) + 11.2 x log(INR) + 9.6 x log(creatinine) + 6.4

Sources: Symptom to Diagnosis: An Evidence-Based Guide, 4th Ed. | Miller's Anesthesia, 10th Ed. | StatPearls - Child-Pugh Score

What are the other criterias like child pugh in hepatic disease

Finding Sources

Searching the Web

scoring systems liver disease severity beyond Child-Pugh MELD UKELD Maddrey criteria comparison

Finding Sources

Reading File

Finding Sources

Reading File

Here is a comprehensive overview of the major scoring systems used in hepatic disease, comparable to the Child-Pugh score:

Scoring Systems in Hepatic Disease

1. MELD Score (Model for End-Stage Liver Disease)

The primary replacement for Child-Pugh in transplant prioritization. It uses objective, lab-based variables only - removing the subjective parameters (ascites, encephalopathy) that limit Child-Pugh.

Original MELD formula:

3.8 x ln(bilirubin mg/dL) + 11.2 x ln(INR) + 9.6 x ln(creatinine mg/dL) + 6.4

Score range: 6 to 40
Interpretation: 1% increase in 30-day mortality per MELD point below 20; additional 2% increase per point above 20
Uses: Transplant waitlist prioritization (USA), predicts 90-day mortality, post-TIPS outcomes

2. MELD-Na (MELD + Sodium)

Adds serum sodium to the MELD formula, improving prediction of mortality in patients with cirrhosis and hyponatremia.

Hyponatremia (low Na) is an independent predictor of waitlist mortality not captured by MELD alone
Currently the standard allocation formula used by UNOS in the United States

3. MELD 3.0

The most recent update to the MELD score (2022), developed to address sex-based disparities (women were disadvantaged on waitlists under older MELD).

MELD 3.0 formula (from Sabiston Surgery, 2024):

MELD = 1.33*(Female sex) + 4.56*(ln bilirubin) + 0.82*(137 - Na) - 0.24*(137-Na)ln(bilirubin) + 9.09(ln INR) + 11.14*(ln creatinine) + 1.85*(3.5 - albumin) - 1.83*(3.5-albumin)*ln(creatinine) + 6

Adds female sex and albumin as variables
Provides better differentiation and corrects sex disparity

4. PELD Score (Pediatric End-Stage Liver Disease)

Used for children under 12 years old in place of MELD for transplant prioritization.

Uses: bilirubin, INR, albumin, growth failure, and age < 1 year as variables

5. Maddrey Discriminant Function (MDF) - Alcoholic Hepatitis Specific

Used specifically to assess severity of alcoholic hepatitis and guide steroid treatment.

Formula:

MDF = 4.6 x (Patient PT - Control PT in seconds) + Serum bilirubin (mg/dL)

Score	Interpretation
< 32	Mild disease, conservative management
≥ 32	Severe disease - high short-term mortality (25-35% at 1 month); consider steroids (prednisolone 40 mg/day)

6. GAHS (Glasgow Alcoholic Hepatitis Score)

Another scoring tool for alcoholic hepatitis, sometimes used alongside MDF.

Variable	1 point	2 points	3 points
Age	< 50	≥ 50	-
WBC	< 15	≥ 15	-
Urea (mmol/L)	< 5	≥ 5	-
PT ratio / INR	< 1.5	1.5-2.0	> 2.0
Bilirubin (μmol/L)	< 125	125-250	> 250

Score ≥ 9 predicts poor prognosis; steroids recommended

7. King's College Criteria (KCC) - Acute Liver Failure

Used in acute liver failure (fulminant hepatic failure) to identify patients who need urgent liver transplantation.

For acetaminophen (paracetamol) toxicity:

pH < 7.30 after resuscitation, OR
All three: PT > 100 sec + creatinine > 300 μmol/L + Grade III-IV encephalopathy

For non-paracetamol causes:

PT > 100 sec, OR
Any 3 of: age <10 or >40, bilirubin > 300 μmol/L, PT > 50 sec, jaundice-to-encephalopathy interval > 7 days, non-A/non-B hepatitis or drug reaction

Meeting KCC criteria = very high mortality without transplant; listed as Status 1A (highest priority).

8. ALBI Grade (Albumin-Bilirubin Grade)

A newer, fully objective score used primarily in hepatocellular carcinoma (HCC) and post-hepatic resection risk.

Formula:

ALBI = log10(bilirubin μmol/L) x 0.66 + albumin g/L x (-0.085)

Grade	Score	1-Year Survival Post-Resection
Grade I	≤ -2.60	~100%
Grade II	-2.60 to -1.39	~82%
Grade III	> -1.39	~63%

Advantage over Child-Pugh: no subjective criteria; performs equally well in predicting mortality in cirrhotic HCC patients

9. HVPG (Hepatic Venous Pressure Gradient)

Not a score per se, but an invasive hemodynamic measure used to predict surgical mortality in cirrhosis.

HVPG < 10 mmHg: protective against postoperative decompensation
HVPG > 16 mmHg: independently associated with higher mortality
HVPG > 20 mmHg: very high risk of death (up to 44%)

10. BCLC Staging (Barcelona Clinic Liver Cancer)

Disease-specific to HCC - combines liver function (Child-Pugh class + performance status) with tumor characteristics (size, nodal/metastatic disease) to guide treatment decisions.

Quick Comparison Summary

Score	Disease	Key Variables	Main Use
Child-Pugh	Cirrhosis	Bili, albumin, INR, ascites, encephalopathy	Prognosis, surgical risk
MELD	Cirrhosis/ESLD	Bili, INR, creatinine	Transplant prioritization
MELD-Na	Cirrhosis/ESLD	MELD + sodium	Current US transplant allocation
MELD 3.0	Cirrhosis/ESLD	MELD-Na + sex + albumin	Modern allocation (corrects sex disparity)
PELD	Pediatric ESLD	Bili, INR, albumin, growth	Transplant < 12 years
Maddrey MDF	Alcoholic hepatitis	PT, bilirubin	Steroid therapy decision
GAHS	Alcoholic hepatitis	Age, WBC, urea, PT, bili	Steroid therapy decision
King's College	Acute liver failure	pH, PT, creatinine, encephalopathy	Urgent transplant listing
ALBI	HCC/Post-resection	Albumin, bilirubin	HCC treatment planning
BCLC	HCC	Child-Pugh + tumor + PS	HCC staging and treatment

Sources: Harrison's Principles of Internal Medicine, 22nd Ed. | Sabiston Textbook of Surgery, 2024 | Yamada's Textbook of Gastroenterology, 7th Ed. | Current Surgical Therapy, 14th Ed. | Rosen's Emergency Medicine, 9th Ed.

This is a shared conversation. Sign in to Orris to start your own chat.